Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Bonnet

Showing results (181-190 of 223) with videos related to

Pageof 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working PartyPriya Virappane, Rosemary Gale, Robert Hills, et al.
Blood|January 8, 2010
Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fractionDavid C Taussig, Jacques Vargaftig, Farideh Miraki-Moud, et al.
Plos One|October 15, 2015
Natural Killer Cells Improve Hematopoietic Stem Cell Engraftment by Increasing Stem Cell Clonogenicity In Vitro and in a Humanized Mouse ModelMichelle Escobedo-Cousin, Nicola Jackson, Raquel Laza-Briviesca, et al.
Plos One|December 15, 2010
Homodimerization of the death-associated protein kinase catalytic domain: development of a new small molecule fluorescent reporterMichael Zimmermann, Cédric Atmanene, Qingyan Xu, et al.
Blood|June 5, 2008
Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cellsDavid C Taussig, Farideh Miraki-Moud, Fernando Anjos-Afonso, et al.
Science Translational Medicine|June 22, 2022
CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemiaWilliam Grey, Ana Rio-Machin, Pedro Casado, et al.
Journal of Medicinal Chemistry|September 11, 2018
LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of AutismMarie-Céline Frantz, Lucie P Pellissier, Elsa Pflimlin, et al.
Blood Cancer Discovery|March 29, 2021
Ectopic humanized mesenchymal niche in mice enables robust engraftment of myelodysplastic stem cellsSyed A Mian, Ander Abarrategi, Kar Lok Kong, et al.
Computational and Structural Biotechnology Journal|November 11, 2024
Biased activation of the vasopressin V2 receptor probed by molecular dynamics simulations, NMR and pharmacological studiesAurélien Fouillen, Pierre Couvineau, Gérald Gaibelet, et al.
Cancer Research|March 11, 2016
Frequency and Dynamics of Leukemia-Initiating Cells during Short-term Ex Vivo Culture Informs Outcomes in Acute Myeloid Leukemia PatientsEmmanuel Griessinger, Fernando Anjos-Afonso, Jacques Vargaftig, et al.
Pageof 23

Showing results (181-190 of 223) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working PartyPriya Virappane, Rosemary Gale, Robert Hills, et al.
Blood|January 8, 2010
Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fractionDavid C Taussig, Jacques Vargaftig, Farideh Miraki-Moud, et al.
Plos One|October 15, 2015
Natural Killer Cells Improve Hematopoietic Stem Cell Engraftment by Increasing Stem Cell Clonogenicity In Vitro and in a Humanized Mouse ModelMichelle Escobedo-Cousin, Nicola Jackson, Raquel Laza-Briviesca, et al.
Plos One|December 15, 2010
Homodimerization of the death-associated protein kinase catalytic domain: development of a new small molecule fluorescent reporterMichael Zimmermann, Cédric Atmanene, Qingyan Xu, et al.
Blood|June 5, 2008
Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cellsDavid C Taussig, Farideh Miraki-Moud, Fernando Anjos-Afonso, et al.
Science Translational Medicine|June 22, 2022
CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemiaWilliam Grey, Ana Rio-Machin, Pedro Casado, et al.
Journal of Medicinal Chemistry|September 11, 2018
LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of AutismMarie-Céline Frantz, Lucie P Pellissier, Elsa Pflimlin, et al.
Blood Cancer Discovery|March 29, 2021
Ectopic humanized mesenchymal niche in mice enables robust engraftment of myelodysplastic stem cellsSyed A Mian, Ander Abarrategi, Kar Lok Kong, et al.
Computational and Structural Biotechnology Journal|November 11, 2024
Biased activation of the vasopressin V2 receptor probed by molecular dynamics simulations, NMR and pharmacological studiesAurélien Fouillen, Pierre Couvineau, Gérald Gaibelet, et al.
Cancer Research|March 11, 2016
Frequency and Dynamics of Leukemia-Initiating Cells during Short-term Ex Vivo Culture Informs Outcomes in Acute Myeloid Leukemia PatientsEmmanuel Griessinger, Fernando Anjos-Afonso, Jacques Vargaftig, et al.
Pageof 23